In elderly patients with T2DM, GLP-1RAs have been shown to have the potential not only to control glycemia, but also to improve cognitive function and gait disorders [35]
to reduce the risk of sustained estimated GFR (eGFR) decline, ESRD, and CV death in patients with type 2 diabetes mellitus and chronic kidney disease Ozempic and Rybelsus tablets: To reduce the risk of major CV events in patients with type 2 diabetes mellitus who are at high risk for these events Wegovy (injection and tablets): In combination with a reduced calorie diet and increased physical activity, to reduce the risk of major adverse CV events in patients with established CV disease and either obesity or overweight Usual Adult Dose for Renal Risk Reduction Ozempic Injection: Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week Maintenance dose: After at least 4 weeks on the 0.5 mg dose, increase to 1 mg subcutaneously once a week
RES20400-A7
Vitamin C injections are generally well tolerated at medically appropriate doses, but high doses can lead to iron overload, kidney stones, and kidney damage
A 97/100 in True Cost Analysis reflects what might be the most honestly all-inclusive pricing model Ive reviewed: flat fees, no dose increases, no hidden charges, and a comprehensive support program that most clinics charge extra for